Search for: "Air Devices, Inc. v. Air Factors, Inc. et al"
Results 1 - 20
of 30
Sorted by Relevance
|
Sort by Date
23 Feb 2009, 7:08 am
(Federal Insurance Co., et al., v. [read post]
9 Nov 2014, 6:46 pm
The Commission is a body created under the Sentencing Reform Act of 1984 (Act), as amended, 18 U.S.C. 3551 et seq. (1982 ed., Supp. [read post]
6 Aug 2013, 8:36 am
Linde Air Products Co., 339 U.S. 605, 608, 70 S. [read post]
21 Dec 2009, 5:24 am
(Business IP and Intangible Asset Report and Blog) Global - Patents New exchange, Intellectual Property Exchange International, can be a game-changer, but will need good patents to thrive (IAM) (Technology Transfer Tactics) Australia Bittersweet decision for Mars but Cadbury settles purple dispute: Mars Australia Pty Ltd v Sweet Rewards Pty Ltd (Managing IP) (ipwars) Belgium Belgian Supreme Court prohibits fishing expeditions: Ineos Manufacturing Belgium NV and Ineos… [read post]
12 Jul 2010, 5:46 am
Seagate Technology et al. [read post]
27 Feb 2011, 9:49 pm
Entertainment, et al. v. [read post]
29 May 2012, 4:48 am
Pneumo Abex et al. [read post]
19 Sep 2010, 10:39 pm
Artesyn Technologies, Inc. et al. [read post]
18 May 2010, 1:10 am
Source Photonics, Inc. et al. [read post]
31 Jan 2011, 9:12 pm
Easton Enterprises et al (CAFC 2010-1057, -1116) precedential Tokai didn't get evidence in because of procedural error: failure to submit written reports for its experts, Jones and Sung. [read post]
3 Jun 2022, 10:03 am
Contractors Inc. v. [read post]
23 Aug 2010, 1:22 am
Medical Device (Patently-O) Impact of case management order: CAFC decision in Baran v. [read post]
22 Aug 2011, 4:48 am
ECORE International Inc., et al. [read post]
22 Aug 2011, 4:48 am
ECORE International Inc., et al. [read post]
9 May 2011, 4:28 am
Garber (Docket Report) District Court N D Illinois: Court analogizes inequitable conduct pleading to false marking pleading: Patent Compliance Group, Inc. v. [read post]
17 May 2016, 9:57 am
Center For Biological Diversity, et al. v. [read post]
17 Mar 2020, 1:32 pm
For instance, when evaluating a company’s medical device recall strategy, the FDA considers several factors, including (but not limited to): Results of a health hazard evaluation assessing the extent of any harm done, to whom, for how long. [read post]
18 Jan 2007, 7:53 pm
In Brennan et al. v. [read post]
19 Jan 2016, 8:00 am
Axanar Productions, Inc. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
